Previous close | 76.46 |
Open | 77.40 |
Bid | 74.16 x 100 |
Ask | 76.81 x 100 |
Day's range | 75.30 - 78.69 |
52-week range | 64.14 - 100.19 |
Volume | |
Avg. volume | 18,825 |
Market cap | 365.91M |
Beta (5Y monthly) | 1.19 |
PE ratio (TTM) | 21.38 |
EPS (TTM) | 3.54 |
Earnings date | 17 Jul 2024 - 22 Jul 2024 |
Forward dividend & yield | 4.00 (5.19%) |
Ex-dividend date | 10 May 2024 |
1y target est | N/A |
EDEN PRAIRIE, Minn., May 06, 2024 (GLOBE NEWSWIRE) -- NVE Corporation (Nasdaq: NVEC) announced with sadness that Richard W. Kramp, a member of the Company’s Board of Directors, passed away after an illness. Mr. Kramp was first elected to NVE’s Board in 2014 after a long and distinguished career in the medical device industry. Most recently, he was CEO of Synovis Life Technologies, Inc., a diversified medical device company, from 2007 to 2012. “Rich has been a valuable member of our Board of Dire
NVE Corporation's ( NASDAQ:NVEC ) investors are due to receive a payment of $1.00 per share on 31st of May. This means...
NVE ( NASDAQ:NVEC ) Full Year 2024 Results Key Financial Results Revenue: US$29.8m (down 22% from FY 2023). Net income...